Filing excerpt
In September 2026, Abbott launched SimpleScreen™ CRC, an FDA approved blood-based colorectal cancer screening test for adults age 45 and older who are at average risk for the disease.
Source: Autobound Signal API · 112 signals tracked for Abbott · updated
Get Abbott's live signals in Claude or ChatGPT, or by API
What changed at Abbott this week? Use Autobound signals for abbott.com.Abbott launched SimpleScreen CRC, an FDA-approved blood-based colorectal cancer screening test, in September 2026 and secured FDA approval for TactiFlex Duo and Libre Duo. These launches may generate demand for specialized commercialization, laboratory logistics, and digital health software solutions.
Filing excerpt
In September 2026, Abbott launched SimpleScreen™ CRC, an FDA approved blood-based colorectal cancer screening test for adults age 45 and older who are at average risk for the disease.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-10qproductLaunchGet every 10-Q signal for Abbott and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/91d27e9a-01b5-439a-9f4a-cdb06f289e16 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.
{
"signal_id": "91d27e9a-01b5-439a-9f4a-cdb06f289e16",
"signal_type": "sec-10q",
"signal_subtype": "productLaunch",
"detected_at": "2026-11-10T08:02:40.333+00:00",
"company": {
"name": "Abbott",
"domain": "abbott.com"
},
"data": {
"detail": "Abbott launched SimpleScreen CRC, an FDA-approved blood-based colorectal cancer screening test, in September 2026 and secured FDA approval for TactiFlex Duo and Libre Duo. These launches may generate demand for specialized commercialization, laboratory logistics, and digital health software solutions.",
"metrics": {
"timeframe": "current_quarter"
},
"quarter": "Q3",
"summary": "Abbott launched SimpleScreen CRC and secured FDA approvals for TactiFlex Duo and Libre Duo in 2026",
"excerpts": "In September 2026, Abbott launched SimpleScreen™ CRC, an FDA approved blood-based colorectal cancer screening test for adults age 45 and older who are at average risk for the disease.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/abt-20260930.htm",
"filing_date": "2026-11-04",
"filing_year": 2026,
"fiscal_year": 2026,
"fiscal_year_end": "09/30",
"period_end_date": "2026-09-30",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
],
"technologies_mentioned": [
"pulsed field ablation",
"radiofrequency",
"biowearable sensor"
]
}
}
curl https://signals.autobound.ai/v1/signals/91d27e9a-01b5-439a-9f4a-cdb06f289e16 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbott.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.